These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16832156)

  • 1. Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90.
    Nakamura K; Okamura T; Hayakawa T; Kadowaki T; Kita Y; Okayama A; Ueshima H;
    Hypertens Res; 2006 May; 29(5):353-60. PubMed ID: 16832156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of ST-T abnormalities and left high R waves with cardiovascular mortality in Japanese (24-year follow-up of NIPPON DATA80).
    Rumana N; Turin TC; Miura K; Nakamura Y; Kita Y; Hayakawa T; Choudhury SR; Kadota A; Nagasawa SY; Fujioshi A; Takashima N; Okamura T; Okayama A; Ueshima H;
    Am J Cardiol; 2011 Jun; 107(12):1718-24. PubMed ID: 21497783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy.
    Verdecchia P; Angeli F; Cavallini C; Mazzotta G; Repaci S; Pede S; Borgioni C; Gentile G; Reboldi G
    J Hypertens; 2009 Aug; 27(8):1697-704. PubMed ID: 19424088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese -- Nippon data 80.
    Lida M; Ueda K; Okayama A; Kodama K; Sawai K; Shibata S; Tanaka S; Keijnkai T; Horibe H; Minowa M; Yanagawa H; Hashimoto T;
    J Hum Hypertens; 2003 Dec; 17(12):851-7. PubMed ID: 14704729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of prolonged ventricular repolarization in hypertension.
    Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
    Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study.
    Salles GF; Cardoso CR; Muxfeldt ES
    J Hypertens; 2009 May; 27(5):1094-101. PubMed ID: 19390353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
    Smebye ML; Iversen EK; Høieggen A; Flaa A; Os I; Kjeldsen SE; Olsen MH; Chattopadhyay A; Hille DA; Lyle PA; Devereux RB; Dahlöf B
    Am J Cardiol; 2007 Sep; 100(5):855-9. PubMed ID: 17719333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
    Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study.
    Rose KM; Eigenbrodt ML; Biga RL; Couper DJ; Light KC; Sharrett AR; Heiss G
    Circulation; 2006 Aug; 114(7):630-6. PubMed ID: 16894039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) Cohort Study.
    Ishikawa S; Shibano Y; Asai Y; Kario K; Kayaba K; Kajii E
    Hypertens Res; 2007 Jul; 30(7):643-9. PubMed ID: 17785933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
    Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH
    J Hypertens; 2009 Jun; 27(6):1165-71. PubMed ID: 19387364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000.
    Kadota A; Hozawa A; Okamura T; Kadowak T; Nakmaura K; Murakami Y; Hayakawa T; Kita Y; Okayama A; Nakamura Y; Kashiwagi A; Ueshima H;
    Diabetes Care; 2007 Jun; 30(6):1533-8. PubMed ID: 17363755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial augmentation index is related to cardiovascular risk in hemodialysis patients.
    Nishiura R; Kita T; Yamada K; Komatsu H; Hara S; Sato Y; Fujimoto S
    Ther Apher Dial; 2008 Apr; 12(2):157-63. PubMed ID: 18387166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up.
    Hozawa A; Okamura T; Murakami Y; Kadowaki T; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Abbott RD; Okayama A; Ueshima H;
    Hypertens Res; 2007 Dec; 30(12):1169-75. PubMed ID: 18344621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is blood pressure during the night more predictive of cardiovascular outcome than during the day?
    Li Y; Boggia J; Thijs L; Hansen TW; Kikuya M; Björklund-Bodegård K; Richart T; Ohkubo T; Kuznetsova T; Torp-Pedersen C; Lind L; Ibsen H; Imai Y; Wang J; Sandoya E; O'brien E; Staessen JA;
    Blood Press Monit; 2008 Jun; 13(3):145-7. PubMed ID: 18496289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
    Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.